Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Sarcoma 3 Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Neuroblastoma 2 Lung Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia-Lymphoma, Adult T-Cell 1 Kidney Neoplasms 1 Histiocytoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fibrosarcoma 1 Esophageal Neoplasms 1 Dysgerminoma 1 Dermatofibrosarcoma 1

Interventions

Temozolomide 128 Radiotherapy 85 Bevacizumab 43 Radiation 30 Carmustine 29 Irinotecan 22 Erlotinib Hydrochloride 22 Magnetic Resonance Spectroscopy 21 Chemotherapy, Adjuvant 20 Surgical Procedures, Operative 15 O(6)-benzylguanine 15 Carboplatin 14 Radiotherapy, Intensity-Modulated 13 Radiotherapy, Conformal 13 sargramostim 12 Sirolimus 9 Imatinib Mesylate 9 Filgrastim 9 temsirolimus 8 Thalidomide 8 Sorafenib 8 Radiosurgery 8 Drug Therapy 8 pembrolizumab 7 motexafin gadolinium 7 aldesleukin 7 Vorinostat 7 Procarbazine 7 Gene Expression Profiling 7 Gefitinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Gliosarcoma × Albumin-Bound Paclitaxel × CNS × Clear all

NCT04528680 2026-04-13

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡